| 000 | 01332 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514181158.0 | ||
| 264 | 0 | _c20040227 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.291.8.1000 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLincoff, A Michael | |
| 245 | 0 | 0 |
_aCoupling drug and catheter therapy for myocardial infarction. _h[electronic resource] |
| 260 |
_bJAMA _cFeb 2004 |
||
| 300 |
_a1000-2 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAbciximab |
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aCardiac Catheterization |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xtherapeutic use |
| 650 | 0 | 4 |
_aMyocardial Infarction _xtherapy |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPremedication |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xtherapeutic use |
| 773 | 0 |
_tJAMA _gvol. 291 _gno. 8 _gp. 1000-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.291.8.1000 _zAvailable from publisher's website |
| 999 |
_c14704192 _d14704192 |
||